Serum lipids, lipoproteins, and risk of breast cancer: A nested case-control study using multiple time points

Journal of the National Cancer Institute

Volumn 107, Issue 5, 2015, Pages

  Martin, Lisa J ^a   Melnichouk, Olga ^a   Huszti, Ella ^a   Connelly, Philip W ^b,c   Greenberg, Carolyn V ^a   Minkin, Salomon ^a   Boyd, Norman F ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ESTROGEN RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LIPOPROTEIN; NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; APOA1 PROTEIN, HUMAN; APOB PROTEIN, HUMAN; APOLIPOPROTEIN B100;

ADULT; ARTICLE; BODY MASS; BREAST CANCER; BREAST DENSITY; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FAMILY HISTORY; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LOW FAT DIET; MAJOR CLINICAL STUDY; MIDDLE AGED; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRIACYLGLYCEROL BLOOD LEVEL; AGED; BLOOD; BREAST; BREAST NEOPLASMS; CANADA; CONGENITAL MALFORMATION; ESTROGEN THERAPY; MAMMARY GLAND; MENOPAUSE; PATHOLOGY; RISK ASSESSMENT; RISK FACTOR; TIME;

ADULT; AGED; APOLIPOPROTEIN A-I; APOLIPOPROTEIN B-100; BREAST; BREAST NEOPLASMS; CANADA; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; MENOPAUSE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TRIGLYCERIDES;

EID: 84928433795     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djv032     Document Type: Article

References (46)

1. Muir C, Waterhouse T, Mack J, Powell S, Whelan S. Cancer Incidence in Five Continents. Volume V1 ed. IARC Scientific Publication; 1992.
2. Yasui Y, Potter JD. The shape of age-incidence curves of female breast cancer by hormone-receptor status. Cancer Causes Control. 1999;10(5):431-437.
3. Ziegler RG, Hoover RN, Pike MC, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst. 1993;85(22):1819-1827.
4. Stanford JL, Herrinton LJ, Schwartz SM, Weiss NS. Breast cancer incidence in Asian migrants to the United States and their descendants. Epidemiology. 1995;6(2):181-183.
5. Pike MC, Kolonel LN, Henderson BE, et al. Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in Whites. Cancer Epidemiol Biomarkers Prev. 2002;11(9):795-800.
6. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer. 1975;15(4):617-631.
7. Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356(3):227-236.
8. Boyd NF, Connelly P, Byng J, et al. Plasma lipids, lipoproteins, and mammographic densities. Cancer Epidemiol Biomarkers Prev. 1995;4(7):727-733.
9. Boyd NF, McGuire V. Evidence of association between plasma high density lipoprotein cholesterol and risk factors for breast cancer. J Natl Cancer Inst. 1990;82(6):460-468.
10. Martin LJ, Li Q, Melnichouk O, et al. A randomized trial of dietary intervention for breast cancer prevention. Cancer Res. 2011;71(1):123-133.
11. Pan W. Akaike's Infrormation Criterion in generalized estimating equations. Biometrics. 2001;57(1):120-125.
12. Hardin J, Hilbe J. Generalized Estimating Equations. London: Chapman and Hall/CRC; 2003.
13. Carroll RJ, Ruppert D, Stefanski LA. Measurement error in nonlinear models. First edition ed. Chapman & Hall; 1995.
14. Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol. 2001;2(3):133-140.
15. Ferraroni M, Gerber M, Decarli A, et al. HDL-cholesterol and breast cancer: A joint study in Northern Italy and Southern France. Int J Epidemiol. 1993;22(5):772-780.
16. Melvin JC, Seth D, Holmberg L, et al. Lipid profiles and risk of breast and ovarian cancer in the Swedish AMORIS Study. Cancer Epidemiol Biomarkers Prev. 2012;21(8):1381-1384.
17. Moorman PG, Hulka BS, Hiatt RA, et al. Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status. Cancer Epidemiol Biomarkers Prev. 1998;7(6):483-488.
18. Kabat GC, Kim M, Chlebowski RT, et al. A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2009;18(7):2046-2053.
19. Agnoli C, Berrino F, Abagnato CA, et al. Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: A nested case-control study. Nutr Metab Cardiovasc Dis. 2010;20(0):41-48.
20. Kucharska-Newton AM, Rosamond WD, Mink PJ, Alberg AJ, Shahar E, Folsom AR. HDL-cholesterol and incidence of breast cancer in the ARIC cohort study. Ann Epidemiol. 2008;18(9):671-677.
21. Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst. 2004;96(15):1152-1160.
22. Hoyer AP, Engholm G. Serum lipids and breast cancer risk: A cohort study of 5,207 Danish women. Cancer Causes Control. 1992;3(5):403-408.
23. Tamimi RM, Byrne C, Colditz GA, Hankinson SE. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2007;99(15):1178-1187.
24. Reed RG, Kris-Etherton P, Stewart PW, Pearson TA. Variation of lipids and lipoproteins in premenopausal women compared with men and postmenopausal women. DELTA (Dietary Effects on Lipoproteins and Thrombogenic Activity) Investigators. Metabolism. 2000;49(9):1101-1105.
25. Barnett JB, Woods MN, Lamon-Fava S, et al. Plasma lipid and lipoprotein levels during the follicular and luteal phases of the menstrual cycle. J Clin Endocrinol Metab. 2004;89(2):776-782.
26. Mumford SL, Schisterman EF, Siega-Riz AM, et al. A longitudinal study of serum lipoproteins in relation to endogenous reproductive hormones during the menstrual cycle: findings from the BioCycle study. J Clin Endocrinol Metab. 2010;95(9):E80-E85.
27. Elhadd TA, Neary R, Abdu TA, et al. Influence of the hormonal changes during the normal menstrual cycle in healthy young women on soluble adhesion molecules, plasma homocysteine, free radical markers and lipoprotein fractions. Int Angiol. 2003;22(3):222-228.
28. Magkos F, Patterson BW, Mittendorfer B. No effect of menstrual cycle phase on basal very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics. Am J Physiol Endocrinol Metab. 2006;291(6):E1243-E1249.
29. Shelley JM, Green A, Smith AM, et al. Relationship of endogenous sex hormones to lipids and blood pressure in mid-aged women. Ann Epidemiol. 1998;8(1):39-45.
30. Derby CA, Crawford SL, Pasternak RC, Sowers M, Sternfeld B, Matthews KA. Lipid changes during the menopause transition in relation to age and weight: The Study of Women's Health Across the Nation. Am J Epidemiol. 2009;169(11):1352-1361.
31. Worsley R, Robinson PJ, Bell RJ, Moufarege A, Davis SR. Endogenous estrogen and androgen levels are not independent predictors of lipid levels in postmenopausal women. Menopause. 2013;20(6):640-645.
32. Mudali S, Dobs AS, Ding J, Cauley JA, Szklo M, Golden SH. Endogenous postmenopausal hormones and serum lipids: The atherosclerosis risk in communities study. J Clin Endocrinol Metab. 2005;90(2):1202-1209.
33. Suzuki R, Orsini N, Mignone L, Saji S, Wolk A. Alcohol intake and risk of breast cancer defined by estrogen and progesterone receptor status-a meta-analysis of epidemiological studies. Int J Cancer. 2008;122(8):1832-1841.
34. Hankinson SE, Willett WC, Manson JE, et al. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst. 1995;87(17):1297-1302.
35. Williams PT, Vranizan KM, Austin MA, Krauss RM. Associations of age, adiposity, alcohol intake, menstrual status, and estrogen therapy with high-density lipoprotein subclasses. Arterioscler Thromb. 1993;13(11):1654-1661.
36. Volcik KA, Ballantyne CM, Fuchs FD, Sharrett AR, Boerwinkle E. Relationship of alcohol consumption and type of alcoholic beverage consumed with plasma lipid levels: differences between Whites and African Americans of the ARIC study. Ann Epidemiol. 2008;18(2):101-107.
37. Brinton EA. Effects of ethanol intake on lipoproteins and atherosclerosis. Curr Opin Lipidol. 2010;21(4):346-351.
38. Baer DJ, Judd JT, Clevidence BA, et al. Moderate alcohol consumption lowers risk factors for cardiovascular disease in postmenopausal women fed a controlled diet. Am J Clin Nutr. 2002;75(3):593-599.
39. Jarvik GP, Wijsman E, Little RE, Albers JJ, Motulsky AG, Brunzell JD. Host and environmental effects on plasma apolipoprotein B. Int J Clin Lab Res. 1993;23(4):215-220.
40. Rotheneder M, Kostner GM. Effects of low-and high density lipoproteins on the proliferation of human breast cancer cell lines in vitro: differences between hormone-dependent and hormone-independent cell lines. Int J Cancer. 1989;43(5):875-879.
41. Danilo C, Gutierriz-Pajares JL, Mainieri MA, Mercier I, Lisanti MP, Frank PG. Scavenger receptor class B type 1 regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development. Breast Cancer Res. 2013;15(0):R87.
42. Salpeter SR, Walsh JM, Ormiston TM, Greyber E, Buckley NS, Salpeter EE. Metaanalysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab. 2006;8(5):538-554.
43. Wang X, Magkos F, Mittendorfer B. Sex differences in lipid and lipoprotein metabolism: it's not just about sex hormones. J Clin Endocrinol Metab. 2011;96(4):885-893.
44. Boyd NF, McGuire V, Fishell E, Kriukov V, Lockwood G, Tritchler D. Plasma lipids in premenopausal women with mammographic dysplasia. Br J Cancer. 1989;59(5):766-771.
45. Boyd NF, Connelly P, Lynch H, et al. Plasma lipids, lipoproteins, and familial breast cancer. Cancer Epidemiol Biomarkers Prev. 1995;4(2):117-122.
46. Langsted A, Freiberg JJ, Nordestgaard BG. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation. 2008;118(20):2047-2056.